Daiken Biomedical Co (TPE:7780) Beneish M-Score: -1.97 (As of Jul. 06, 2026)


TPE:7780 Daiken Biomedical Co Ltd TPE:7780
23 GF Score
Price NT$18.35
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co Beneish M-Score?

Daiken Biomedical Co TPE:7780 +1.66% 23 Beneish M-Score is -1.97 as of Jul. 06, 2026. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,849 Consumer Packaged Goods companies, Daiken Biomedical Co ranks worse than 79.02% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.97 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Daiken Biomedical Co's Beneish M-Score or its related term are showing as below:

TPE:7780' s Beneish M-Score Range Over the Past 10 Years
Min: -1.97   Med: -1.97   Max: -1.97
Current: -1.97

During the past 4 years, the highest Beneish M-Score of Daiken Biomedical Co was -1.97. The lowest was -1.97. And the median was -1.97.


Daiken Biomedical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiken Biomedical Co Beneish M-Score Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 0.00 -1.97

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -1.28 -1.86 -1.97

TPE:7780 vs KHC, GIS: Beneish M-Score Comparison

For the Packaged Foods subindustry, Daiken Biomedical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daiken Biomedical Co Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Daiken Biomedical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Daiken Biomedical Co's Beneish M-Score falls into.


TPE:7780
23GF Score
Daiken Biomedical Co Ltd TPE:7780
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Daiken Biomedical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0964+0.528 * 0.9878+0.404 * 0.3423+0.892 * 1.391+0.115 * 2.1187
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9357+4.679 * 0.01104-0.327 * 0.5207
=-1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$144 Mil.
Revenue was 656.111 + 449.325 + 454.879 + 334.774 = NT$1,895 Mil.
Gross Profit was 401.285 + 287.935 + 293.488 + 223.021 = NT$1,206 Mil.
Total Current Assets was NT$5,863 Mil.
Total Assets was NT$5,913 Mil.
Property, Plant and Equipment(Net PPE) was NT$19 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$7 Mil.
Selling, General, & Admin. Expense(SGA) was NT$906 Mil.
Total Current Liabilities was NT$447 Mil.
Long-Term Debt & Capital Lease Obligation was NT$15 Mil.
Net Income was 124.644 + 69.423 + 38.798 + 105.002 = NT$338 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 123.048 + 34.63 + 62.572 + 52.34 = NT$273 Mil.
Total Receivables was NT$94 Mil.
Revenue was 543.915 + 294.044 + 283.477 + 240.951 = NT$1,362 Mil.
Gross Profit was 344.785 + 191.203 + 191.407 + 128.822 = NT$856 Mil.
Total Current Assets was NT$1,511 Mil.
Total Assets was NT$1,538 Mil.
Property, Plant and Equipment(Net PPE) was NT$3 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$4 Mil.
Selling, General, & Admin. Expense(SGA) was NT$696 Mil.
Total Current Liabilities was NT$230 Mil.
Long-Term Debt & Capital Lease Obligation was NT$0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(143.587 / 1895.089) / (94.153 / 1362.387)
=0.075768 / 0.069109
=1.0964

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(856.217 / 1362.387) / (1205.729 / 1895.089)
=0.628468 / 0.636239
=0.9878

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5863.066 + 19.253) / 5912.651) / (1 - (1511.468 + 3.284) / 1537.801)
=0.00513 / 0.014988
=0.3423

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1895.089 / 1362.387
=1.391

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.214 / (4.214 + 3.284)) / (6.951 / (6.951 + 19.253))
=0.562017 / 0.265265
=2.1187

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(906.213 / 1895.089) / (696.257 / 1362.387)
=0.47819 / 0.511057
=0.9357

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((15.178 + 446.872) / 5912.651) / ((0.446 + 230.366) / 1537.801)
=0.078146 / 0.150092
=0.5207

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(337.867 - 0 - 272.59) / 5912.651
=0.01104

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Daiken Biomedical Co has a M-score of -1.97 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -1.97 mean?
Daiken Biomedical Co (TPE:7780) has a Beneish M-Score of -1.97 as of Jul. 06, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Daiken Biomedical Co and its competitors. According to the industry distribution chart, Daiken Biomedical Co ranks #1461 out of 1849 companies in the Consumer Packaged Goods industry, placing it in the top 79%.
Is Daiken Biomedical Co's Beneish M-Score too high?
Daiken Biomedical Co's current Beneish M-Score is -1.97. Based on the distribution chart, Daiken Biomedical Co ranks #1461 out of 1849 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Beneish M-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Daiken Biomedical Co ranks #1461 out of 1849 companies for Beneish M-Score. This places Daiken Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current Beneish M-Score is -1.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Beneish M-Score of -1.97. The current Beneish M-Score is -1.97. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Beneish M-Score is -1.97 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score

Get the complete analysis for TPE:7780

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.35
Price